Get the Stockscreener App
6.21
0.80%
-0.05
After Hours:
6.21
Zura Bio Ltd stock is traded at $6.21, with a volume of 214.29K.
It is down -0.80% in the last 24 hours and up +20.35% over the past month.
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
See More
Previous Close:
$6.26
Open:
$6.33
24h Volume:
214.29K
Relative Volume:
0.36
Market Cap:
$403.79M
Revenue:
-
Net Income/Loss:
$-60.36M
P/E Ratio:
-1.4133
EPS:
-4.394
Net Cash Flow:
$-15.05M
1W Performance:
+9.52%
1M Performance:
+20.35%
6M Performance:
+322.45%
1Y Performance:
+340.43%
1-Day Range:
$6.01
$6.405
1-Week Range:
$5.59
$6.88
52-Week Range:
$0.97
$6.88
Zura Bio Ltd Stock (ZURA) Company Profile
Name
Zura Bio Ltd
Sector
Industry
Phone
858-247-0520
Address
4225 EXECUTIVE SQUARE, LA JOLLA
Compare ZURA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZURA
Zura Bio Ltd
|
6.21 | 407.05M | 0 | -60.36M | -15.05M | -4.394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Initiated | Wedbush | Outperform |
| Nov-04-24 | Initiated | Leerink Partners | Outperform |
| Sep-05-24 | Initiated | H.C. Wainwright | Neutral |
| May-03-24 | Initiated | Piper Sandler | Overweight |
| Oct-10-23 | Initiated | Ladenburg Thalmann | Buy |
| Aug-25-23 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Guggenheim | Buy |
| Jun-14-23 | Initiated | Chardan Capital Markets | Buy |
| May-24-23 | Initiated | Raymond James | Strong Buy |
View All
Zura Bio Ltd Stock (ZURA) Latest News
Zura Bio Advances Tibulizumab Strategy in Autoimmune Diseases - TipRanks
Zura Bio Ltd Provides Updated Corporate Presentation - TradingView
This Nokia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Wedbush initiates coverage on Zura Bio stock with Outperform rating By Investing.com - Investing.com India
Wedbush initiates coverage on Zura Bio stock with Outperform rating - Investing.com
Wedbush Initiates Zura Bio at Outperform With $15 Price Target - marketscreener.com
Investment Report: Will Zura Bio Limited benefit from rising consumer demand2025 Short Interest & AI Driven Price Predictions - baoquankhu1.vn
Aug Update: Will Zura Bio Limited benefit from rising consumer demandJuly 2025 Chart Watch & Safe Capital Allocation Plans - baoquankhu1.vn
Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit - ChartMill
Aug Sectors: What makes Zura Bio Limited stock attractive todayTrade Risk Assessment & Capital Protection Trading Alerts - baoquankhu1.vn
Zura Bio Limited (NASDAQ:ZURA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Pre-market volume spike for 94E.F Zura Bio (XETRA) 28 Jan 2026: watch EUR 5.20 level - Meyka
Zura Bio (NASDAQ:ZURA) Trading Up 0.3%What's Next? - MarketBeat
Does Zura Bio Limited have pricing power2025 Technical Overview & Weekly Consistent Profit Watchlists - mfd.ru
CEO shake-up at Zura Bio (NASDAQ: ZURA) with new director added - Stock Titan
Can Zura Bio Limited stock double in the next yearJuly 2025 Fed Impact & High Return Trade Opportunity Guides - baoquankhu1.vn
Zura Bio appoints Sandeep Kulkarni as new CEO By Investing.com - Investing.com South Africa
Aug Summary: Is OAKPRB stock showing strong momentum2025 Retail Activity & AI Enhanced Trading Alerts - baoquankhu1.vn
Zura Bio stock jumps after CEO appointment from Tourmaline Bio By Investing.com - Investing.com South Africa
Zura Bio stock jumps after CEO appointment from Tourmaline Bio - Investing.com
Progress Software Posts Upbeat Q4 Earnings, Joins ServisFirst Bancshares, Zura Bio And Other Big Stocks Moving Higher On WednesdayAmerican Resources (NASDAQ:AREC), ARM Holdings (NASDAQ:ARM) - Benzinga
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer - Weekly Voice
Ex-Tourmaline CEO who led company’s sale to Novartis takes helm at Zura Bio - Stock Titan
How Zura Bio Limited stock performs during Fed tightening cyclesCandlestick Pattern Analysis & Free Realize Exceptional Returns - bollywoodhelpline.com
RSI Check: What is Zura Bio Limiteds TAM Total Addressable MarketJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - baoquankhu1.vn
Worthington Steel, Immunitybio, Riot Platforms, Micron Technology And Other Big Stocks Moving Higher On Friday - Benzinga
Aug Drivers: Should you avoid Zura Bio Limited stock right nowEarnings Summary Report & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Zura Bio expands HS trial, delays data readout to fourth quarter 2026 - Investing.com Nigeria
Jessica Chen - White & Case LLP
Zura Bio Ltd Announces Corporate and Clinical Updates for 2026 - TradingView — Track All Markets
Zura Bio Reports Business Updates and Outlook for 2026 - Chartmill
Why Zura Bio Limited stock could rally in 2025July 2025 News Drivers & AI Forecasted Stock Moves - Улправда
Why Zura Bio Limited stock attracts high net worth investors2025 Retail Activity & Weekly Sector Rotation Insights - Улправда
Zura Bio 94E.F (XETRA) +16.34% to €4.70 on 08 Jan 2026: Market closed, readout in focus - Meyka
Will Zura Bio Limited stock continue upward momentumMarket Sentiment Summary & Safe Entry Point Identification - Улправда
How Zura Bio Limited (94E) stock correlates with oil marketsPortfolio Gains Summary & Weekly High Return Forecasts - Улправда
Zura Bio LtdOn Dec 29, co and units entered into several agreements - marketscreener.com
94E.F gains 19.90% intraday on XETRA 02 Jan 2026: €4.58 draws analyst focus - Meyka
IPO Launch: How Zura Bio Limited stock valuations compare to rivalsNew Guidance & Consistent Income Trade Recommendations - moha.gov.vn
Zura Bio (NASDAQ:ZURA) Stock Price Down 1.5% – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday - Benzinga
Growth Report: What makes Zura Bio Limited stock attractive to growth fundsWeekly Earnings Recap & AI Enhanced Market Trend Forecasts - Улправда
Is Zura Bio Limited stock supported by strong fundamentalsJuly 2025 Institutional & Fast Moving Stock Trade Plans - Улправда
What makes Zura Bio Limited stock attractive to growth fundsEarnings Recap Report & Precise Trade Entry Recommendations - Улправда
Zura Bio Director Resignation Sparks Governance Adjustments - The Globe and Mail
Zura Bio Ltd Announces Director Resignation - TradingView — Track All Markets
Zura Bio Limited Announces Resignation of Arnout Ploos van Amstel as Director, Effective December 11, 2025 - marketscreener.com
Is Zura Bio Limited (94E) stock good for long term investingJuly 2025 Snapshot & Smart Allocation Stock Tips - Newser
How Zura Bio Limited (94E) stock expands through international marketsJuly 2025 Summary & Expert Approved Trade Ideas - Newser
How cyclical is Zura Bio Limited (94E) stock compared to rivalsJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - Newser
Zura Bio Ltd Stock (ZURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):